| Literature DB >> 29991204 |
Axel Egal1, Isabelle Etienney1, Heym Beate2, Jean Francois Fléjou3, Charles André Cuenod4, Patrick Atienza1, Pierre Bauer1.
Abstract
PURPOSE: Primary anal actinomycosis of cryptoglandular origin, a rare cause of anal suppurative disease, requires specific management to be cured. The aims of this retrospective study were to describe clinical, morphological, and microbiological features of this entity and to evaluate management practices for new cases observed since 2001.Entities:
Keywords: Anal abscess; Cryptoglandular origin; Fistula-in-ano; Actinomycosis
Year: 2018 PMID: 29991204 PMCID: PMC6046537 DOI: 10.3393/ac.2017.07.23
Source DB: PubMed Journal: Ann Coloproctol ISSN: 2287-9714
Characteristics of the patients (n = 7) and fistulae in the present study
| Characteristic | Value |
|---|---|
| Patient | |
| Age (yr) | 49 (19–72) |
| Sex, male : female | 6 (86) : 1 (14) |
| Body mass index (kg/m²) | 28.3 (25–36.7) |
| Active smokers | 3 (43) |
| Inflammatory bowel disease | 1 (14) or 2 (29) |
| NSAIDs | 3 (43) |
| Average number of previous surgeries | 2.6 (1–5) |
| Fistulae | |
| Complexity, single : complex | 0 (0) : 7 (100) |
| Type[ | 6 (86) : 1 (14) |
| Horseshoe extension | 2 (29) |
| High intersphincteric extension | 5 (71) |
| Suprelevatori extension | 2 (29) |
Values are presented as mean (range) or number (%).
NSAID, nonsteroidal anti-inflammatory drug; TS, transsphincteric; SS, suprasphincteric.
According to Park’s classification system [4].
Characteristics of the patients (n = 13), fistulae and antibiotherapies in both studies
| Characteristic | Bauer et al. [1] | Present study | Combination |
|---|---|---|---|
| Patient | |||
| Number of patients | 6 | 7 | 13 |
| Age (yr) | 53 (32–63) | 49 (19–72) | 51 (19–72) |
| Sex, male : female | 5 (83) : 1 (17) | 6 (86) : 1 (14) | 11 (85) : 2 (15) |
| Fistulae | |||
| Complexity, single : complex | 1 (17) : 5 (83) | 0 (0) : 7 (100) | 1 (8) : 12 (92) |
| Type[ | 5 (83) : 1 (17) | 6 (86) : 1 (14) | 11 (85) : 2 (15) |
| Horseshoe extension | 2 (33) | 2 (29) | 4 (31) |
| Oral antibiotic therapy | |||
| Mean duration (wk) | 21.3 (4–78) | 49.1 (16–180) | 36.3 (4–180) |
| Initial antibiotherapy | |||
| Aminopenicillin | 3 (50) (3 to 4 g/day) | 0 (0) | 3 (23) |
| CA | 0 (0) | 5 (71) (3 to 4 g/day) | 5 (39) |
| Amoxicillin + ACA | 1 (17) (1 and 2 g/day) | 2 | (29) (3 g/day each) |
| Tetracyclines | 2 (33) (2 g/day) | 0 (0) | 2 (15) |
Values are presented as mean (range) or number (%).
TS, transsphincteric; SS, suprasphincteric; CA, clavulanic acid; ACA, amoxicillin-clavulanic acid.
According to Park’s classification system [4].
Fig. 1.Actinomycosis in an anal fistula. The characteristics of an actinomycotic granule can be seen, enveloped by a purulent exudate (H&E, ×200).